Hounslow Community Atrial Fibrillation Screening Project
Announcing the roll-out of the innovative new community project NIHR Collaboration for Leadership in Applied Health Research and Care Northwest London (CLAHRC NWL) , Chelsea and Westminster Hospitals NHS Foundation Trust, Hounslow Clinical Commissioning Group and the Arrhythmia Alliance which is set to reduce the risk of a stroke for Hounslow residents.
The project, funded by NIHR CLAHRC NWL and Hounslow CCG and is supported by several industry partners including Samsung and EE, aims to improve the detection and treatment of an abnormal heart rhythm, Atrial Fibrillation (AF), which affects 1 in 4 people over the age of 40 and causes 1 in 5 strokes.
The Hounslow Community Atrial Fibrillation (AF) Project is designed to improve the detection and treatment of AF which may not cause any symptoms. A portable ECG monitor called Kardia® Mobile (developed by AliveCor Ltd) which captures a single lead heart trace over 30 seconds is used to detect AF, to improve choice and speed of treatment. The project has been successfully piloted since February in 5 GP practices within Hounslow and has now been rolled out to all GP surgeries in the Hounslow CCG area.
A West Middlesex patient had a history of occasional palpitations of the heart but struggled to find a diagnosis. Mr Pickles did not want to go down the route of a Holter monitor, a portable device worn continuously for at least 24 hours to monitor heart rhythm, and instead bought his own Kardia® Mobile ECG, which links with his smart phone.
The roll-out of the project is timely as on June 17th Simon Stevens, Chief Executive of NHS England announced a new tariff for medical technology devices from April 2017 in a keynote address at the NHS Confederation Annual Conference in Manchester. Clearly primary care in Hounslow has already embraced this as a concept and are looking forward to seeing the benefits for Hounslow residents.
For more information visit our website: clahrc-northwestlondon.nihr.ac.uk